by qualiaris@wpadmin | Oct 30, 2015 | Uncategorized
Canadian molecular diagnostics firm Qvella is developing a sepsis diagnostic that uses differences in surface charge and mobility to pluck sepsis-causing pathogens from blood samples. The firm announced yesterday that it had raised $20 million in Series A financing to...
by qualiaris@wpadmin | Jun 23, 2015 | Uncategorized
Congrats to our clients at Whitecap Venture Partners on closing their $100 million fund, Whitecap III. “Fund III’s final close comes about six weeks after it secured an initial $70 million and about four months after it was launched to raise between $80 million...
by qualiaris@wpadmin | Apr 27, 2015 | Uncategorized
Canadian venture-capital firm Whitecap Venture Partners has raised 70 million Canadian dollars ($57.5 million) for its latest fund, counting one of Canada’s big banks among its investors. Read...
